Home
Invest
Explore
About
Pricing

Search

Sign In

What are you looking for?

Home
Invest
Explore
About
Pricing
Compare AU

Compare CURE vs. A200

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Industry & Region

Industry & Region


Country Exposure

CURE

A200

United States

97.17 %

3.04 %

Switzerland

1.51 %

United Kingdom of Great Britain and Northern Ireland

1.16 %

0.38 %

Ireland

0.16 %

Australia

95.07 %

New Zealand

1.41 %

China

0.09 %


Industry Exposure

icon for key differences panel

Key differences

  • CURE has a higher allocation (100.00 %) in the Health Care sector than A200 (8.95 %).

  • The most popular industries that CURE is exposed to are Health Care (100.00 %), and Other (10.24 %). Comparatively, A200 is most exposed to Financials (33.81 %), Materials (17.44 %), and Health Care (8.95 %).

CURE

A200

Health Care

100.00 %

8.95 %

Other

10.24 %

3.24 %

Financials

33.81 %

Materials

17.44 %

Consumer Discretionary

7.70 %

Industrials

6.72 %

Real Estate

6.64 %

Energy

3.95 %

Consumer Staples

3.71 %

Communication Services

3.42 %

Information Technology

2.98 %

Utilities

1.44 %